The company has received final approval to market its Flucytosine capsules USP, in the strengths of 250 mg and 500 mg, from the United States Food and Drug Administration (USFDA), Lupin said in a ...
Lupin Ltd has received US FDA approval for its abbreviated new drug application (ANDA) for Cephalexin capsules USP 250mg and 500mg. The US market for Cephalexin Capsules is estimated at $80 million.
Lupin's anti-infection Flucytosine capsule is the generic version of Valeant Pharmaceuticals International Inc.'s Ancobon tablets. Photo: Bloomberg New Delhi: Drug major Lupin on Friday said it has ...
Drug firm Lupin today said the company’s US subsidiary has received tentative approvals for its Armodafinil tablets and Doxycycline capsules from the US health regulator. The company’s US subsidiary, ...
MUMBAI, India & NAPLES, Fla., Feb. 4, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of ...
Drug firm Lupin on Thursday said that in alliance with Concord Biotech, it has received approval from the US health regulator to market generic immunosuppressant Tacrolimus capsules used in the ...
On 19 July 2018, Netflix ordered a new series, to be produced by Gaumont, about the character Arsène Lupin, portrayed by Omar Sy. In a 2018 interview, Sy revealed that "Arsene Lupin, who is an iconic and charismatic character, will take on a new life in this modern adaptation, unique in its genre". [19]
Lupin, a global pharmaceutical company in the U.S., embodies an unwavering commitment to access, quality, and affordability, ensuring the reliable delivery of exceptional products to the market.